Indeed, previous studies have shown that β5‐integrin can regulate cancer cell survival and drug sensitivity through the Src‐Akt pathway.[26] We then conducted Western blot analysis on the downstream effectors of β5‐integrin, Src, and Akt, in cancer cells treated with conditioned medium (CM) from PCs or cancer cells, with or without TKI treatment. The gene discussed is AKT1; the disease is cancer.